Nevertheless, the result of the present investigation opens the pathway to discovering novel TIM-3 variants that could underlie the pathogenesis of a complex autoimmune phenotype in APS patients and identify a specific clustering of association with peculiar clinical manifestations, thus contributing to APS classification and diagnosis. This evidence concerns the gene HAVCR2 and autoimmune polyendocrinopathy.